Prothena Stock Price (NASDAQ:PRTA)

Add to My Stocks
$65.63 $1.61 (2.39%) PRTA stock closing price Jul 25, 2017 (Closing)
Prev Close* : $67.24
Market Cap:
Day Low: $64.48
52 Week Low: $40.58
Open: $67.75
Volume: 410109
Day High: $68.18
52 Week High: $69.53

Latest Stock Market News

Latest Articles

Prothena News - From Partners

PRTA Stockcharts

View PRTA PE ratio, PS ratio stocks charts and compare with peers.
PRTA Chart
Note: Compare Prothena stock price history with the index and industry peers.

Prothena Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Prothena Financial Ratios

Receivables Turnover

PRTA Industry Peers

Company Price Change (%)
Axovant Sciences (AXON)21.81.4 (6.03%)
Ligand Pharma (LGND)123.30.44 (0.36%)
Roche Holdings (RHHBY)31.80.35 (1.09%)
Neuroderm (NDRM)38.60.25 (0.65%)
Voyager Therapeutics (VYGR)9.490.01 (0.11%)
Cynapsus Therapeutics (CYNA)40.480 (0%)
Intec Pharma (NTEC)5.450.2 (3.54%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Compugen (CGEN)4.050.65 (19.12%)
Idera Pharma (IDRA)2.060.14 (7.29%)
Merrimack Pharma (MACK)1.360.05 (3.82%)
PDL BioPharma (PDLI)2.460.08 (3.36%)
Horizon Pharma (HZNP)13.480.32 (2.43%)
Keryx Biopharma (KERX)7.450.16 (2.19%)
Acorda Therapeutics (ACOR)22.850.45 (2.01%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017
CompanyPriceChange (%)
Novavax (NVAX)1.10.41 (27.15%)
Dynavax Technologies (DVAX)9.90.75 (7.04%)
Vital Therapies (VTL)2.650.15 (5.36%)
EXACT Sciences (EXAS)37.332.11 (5.35%)
China Biologic Products (CBPO)98.325.05 (4.89%)
Epizyme (EPZM)12.650.65 (4.89%)
Trevena (TRVN)2.820.14 (4.73%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 26, 2017

Prothena Corporation PLC Stock News - Partner Headlines

Prothena Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.05M1.6M50.85M0.67M2.65M
Net Income-160.1M-80.61M-7.15M-40.99M-41.41M
Total Operating Expense160.58M81.53M57.5M41.1M44.05M
view Prothena Corporation PLC income statement
balance sheet20162015201420132012
Total Assets459.97M385.23M304.11M182.41M129.28M
Total Liabilities94.57M24.56M14.22M9.14M2.79M
Shareholders Equity365.4M360.66M289.88M173.27M126.48M
view Prothena Corporation PLC balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities18.88M11.47M1.37M5.67M-7.22M
Net Cash From (Used By) Operating Activities-117.26M-62.45M-0.68M-32.09M-42.07M
Increase (Decrease) In Prop Plant And Equipment-16.64M-1.38M-0.49M-0.53M-1.3M
view Prothena Corporation PLC cashflow statement

Prothena Stock Message Board

Prothena stock lost -2.39 %, and the last close price as of 25 Jul, 2017 is 65.63 for PRTA stock. Stock price or share price can be used to find the total market value of a company. Prothena market cap stands at 2.56B as of 25 Jul, 2017. Prothena valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Prothena stock price and Prothena share price mean the same thing. The volume number in Prothena stock quote data shows the number of shares traded. For Ex: 410109 Prothena shares were traded as of last trading day, as seen from Prothena stock chart. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. To check the historical stock price movement, all time high, and all time low of PRTA, view Prothena stock price history.